Status:
UNKNOWN
A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
Lead Sponsor:
Hutchison Medipharma Limited
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Phase I, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of HMPL-306 in Patients of Relapsed/Refractory Myeloid Leukemia/Neoplasms with IDH1 and/or IDH2 Mutat...
Detailed Description
The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of HMPL-306 in Patients of Relapsed/Refractory Myeloid Leukemia/Neoplasms with...
Eligibility Criteria
Inclusion
- ≥18 years of age;
- Signed Informed Consent Form;
- Relapsed/refractory Acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia(CMML) and others myeloid neoplasm;
- IDH1 and/or IDH2 mutated disease status as assessed by local laboratory;
- Cooperative Oncology Group (ECOG) performance status of 0-2;
- Subjects must be amenable to serial bone marrow biopsies, peripheral blood sampling, and urine sampling during the study.
Exclusion
- Previously treated with any prior IDH1 inhibitor, IDH2 inhibitor, or IDH1/IDH2 double-targeted therapy and had disease progression during treatment;
- with known involvement or clinical symptoms of central nervous system (CNS);
- Patients who have undergone HSCT within 60 days;
- Without adequate liver or kidney function;
- With known infection with active hepatitis B or C;
- With known infection with human immunodeficiency virus (HIV);
- History of clinically significant or active cardiac disease;
- Active clinically significant infection;
- Taking known strong cytochrome P450 (CYP) 2C8 inducers or inhibitors;
- Pregnancy or breast-feeding.
Key Trial Info
Start Date :
May 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04272957
Start Date
May 14 2020
End Date
December 30 2022
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China